David Kozono, MD, PhD, Director of the Alliance Foundation, and Director of Thoracic Radiation Oncology at Mass General Brigham Cancer Center (IMAGE)
Caption
“To our knowledge, this is the first trial specifically focused lymph node clearance in this population, and the results look very promising,” said David Kozono, MD, PhD, Director of the Alliance Foundation, and Director of Thoracic Radiation Oncology at Mass General Brigham Cancer Center. “The high rates of lymph node clearance and successful surgical resection confirm this approach as an important option for patients with this stage of lung cancer.”
Credit
Mass General Brigham Cancer Center
Usage Restrictions
none
License
Original content